Martin Rutegård1, Petrus Boström2, Markku Haapamäki2, Peter Matthiessen3, Jörgen Rutegård2. 1. Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden. martin.rutegard@surgery.umu.se. 2. Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden. 3. Department of Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Abstract
PURPOSE: A diverting stoma is commonly used to reduce the risk of anastomotic leakage when performing total mesorectal excision (TME) in anterior resection for rectal cancer. The purpose of this study was to evaluate the impact of fecal diversion in relation to partial mesorectal excision (PME). METHODS: A retrospective analysis was undertaken on a national cohort, originally created to study the impact of central arterial ligation on patients with increased cardiovascular risk. Some 741 patients operated with anterior resection for rectal cancer during the years 2007 through 2010 were followed up for 53 months. Multivariate logistic regression was used to evaluate the impact of diverting stoma on the risk of anastomotic leakage and permanent stoma, expressed as odds ratios (ORs) and 95% confidence intervals (CIs). RESULTS: The risk of anastomotic leakage was increased in TME surgery when not using a diverting stoma (OR 5.1; 95% CI 2.2-11.6), while the corresponding risk increase in PME patients was modest (OR 1.8; 95% CI 0.8-4.0). At study completion or death, 26 and 13% of TME and PME patients, respectively, had a permanent stoma. A diverting stoma was a statistically significant risk factor for a permanent stoma in PME patients (OR 4.7; 95% CI 2.5-9.0), while less important in TME patients (OR 1.8; 95% CI 0.6-5.5). CONCLUSION: The benefit of a diverting stoma concerning anastomotic leakage in this patient group seems doubtful. Moreover, the diverting stoma itself may contribute to the high rate of permanent stomas.
PURPOSE: A diverting stoma is commonly used to reduce the risk of anastomotic leakage when performing total mesorectal excision (TME) in anterior resection for rectal cancer. The purpose of this study was to evaluate the impact of fecal diversion in relation to partial mesorectal excision (PME). METHODS: A retrospective analysis was undertaken on a national cohort, originally created to study the impact of central arterial ligation on patients with increased cardiovascular risk. Some 741 patients operated with anterior resection for rectal cancer during the years 2007 through 2010 were followed up for 53 months. Multivariate logistic regression was used to evaluate the impact of diverting stoma on the risk of anastomotic leakage and permanent stoma, expressed as odds ratios (ORs) and 95% confidence intervals (CIs). RESULTS: The risk of anastomotic leakage was increased in TME surgery when not using a diverting stoma (OR 5.1; 95% CI 2.2-11.6), while the corresponding risk increase in PME patients was modest (OR 1.8; 95% CI 0.8-4.0). At study completion or death, 26 and 13% of TME and PME patients, respectively, had a permanent stoma. A diverting stoma was a statistically significant risk factor for a permanent stoma in PME patients (OR 4.7; 95% CI 2.5-9.0), while less important in TMEpatients (OR 1.8; 95% CI 0.6-5.5). CONCLUSION: The benefit of a diverting stoma concerning anastomotic leakage in this patient group seems doubtful. Moreover, the diverting stoma itself may contribute to the high rate of permanent stomas.
Entities:
Keywords:
Defunctioning stoma; Fecal diversion; Permanent stoma; Rectal cancer
Authors: L Påhlman; M Bohe; B Cedermark; M Dahlberg; G Lindmark; R Sjödahl; B Ojerskog; L Damber; R Johansson Journal: Br J Surg Date: 2007-10 Impact factor: 6.939
Authors: M den Dulk; C A M Marijnen; L Collette; H Putter; L Påhlman; J Folkesson; J-F Bosset; C Rödel; K Bujko; C J H van de Velde Journal: Br J Surg Date: 2009-09 Impact factor: 6.939
Authors: Jonas F Ludvigsson; Eva Andersson; Anders Ekbom; Maria Feychting; Jeong-Lim Kim; Christina Reuterwall; Mona Heurgren; Petra Otterblad Olausson Journal: BMC Public Health Date: 2011-06-09 Impact factor: 3.295
Authors: Sami A Chadi; Abe Fingerhut; Mariana Berho; Steven R DeMeester; James W Fleshman; Neil H Hyman; David A Margolin; Joseph E Martz; Elisabeth C McLemore; Daniela Molena; Martin I Newman; Janice F Rafferty; Bashar Safar; Anthony J Senagore; Oded Zmora; Steven D Wexner Journal: J Gastrointest Surg Date: 2016-09-16 Impact factor: 3.452
Authors: Peter W G Tennant; Eleanor J Murray; Kellyn F Arnold; Laurie Berrie; Matthew P Fox; Sarah C Gadd; Wendy J Harrison; Claire Keeble; Lynsie R Ranker; Johannes Textor; Georgia D Tomova; Mark S Gilthorpe; George T H Ellison Journal: Int J Epidemiol Date: 2021-05-17 Impact factor: 7.196
Authors: Georg Emons; Noam Auslander; Peter Jo; Thomas Ried; Jochen Gaedcke; Julia Kitz; Azadeh Azizian; Yue Hu; Clemens F Hess; Claus Roedel; Ulrich Sax; Gabriela Salinas; Philipp Stroebel; Frank Kramer; Tim Beissbarth; Marian Grade; Michael Ghadimi; Eytan Ruppin Journal: Br J Cancer Date: 2022-05-21 Impact factor: 9.075
Authors: Erik Back; Fredrik Brännström; Johan Svensson; Jörgen Rutegård; Peter Matthiessen; Markku M Haapamäki; Martin Rutegård Journal: Langenbecks Arch Surg Date: 2021-05-18 Impact factor: 3.445